Biomarkers for gastric cancer: molecular classification revisited
Jeeyun Lee, Kyoung-Mee Kim
Precis Future Med. 2017;1(2):59-68.   Published online 2017 Jun 30     DOI:
Citations to this article as recorded by Crossref logo
Exploring the Mechanisms of Traditional Chinese Herbal Therapy in Gastric Cancer: A Comprehensive Network Pharmacology Study of the Tiao-Yuan-Tong-Wei decoction
Juan Chen, Jingdong Kang, Shouli Yuan, Peter O’Connell, Zizhu Zhang, Lina Wang, Junying Liu, Rongfeng Chen
Pharmaceuticals.2024; 17(4): 414.     CrossRef
The Role of Latent Transforming Growth Factor β Binding Protein 2 (LTBP2) in the Diagnosis and Stage Discrimination of Gastric Cancer
Tolga Kalayci, Umit Haluk Iliklerden
Indian Journal of Surgery.2022; 84(1): 164.     CrossRef
Gastric Cancer: Mechanisms, Biomarkers, and Therapeutic Approaches
Sangjoon Choi, Sujin Park, Hyunjin Kim, So Young Kang, Soomin Ahn, Kyoung-Mee Kim
Biomedicines.2022; 10(3): 543.     CrossRef
Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer
Cristina Díaz del Arco, Lourdes Estrada Muñoz, Luis Ortega Medina, Elena Molina Roldán, M. Ángeles Cerón Nieto, Soledad García Gómez de las Heras, M. Jesús Fernández Aceñero
World Journal of Gastrointestinal Oncology.2022; 14(6): 1162.     CrossRef
DNA-protein biomarkers for immunotherapy in the era of precision oncology
Binnari Kim, So Young Kang, Kyoung-Mee Kim
Journal of Pathology and Translational Medicine.2021; 55(1): 26.     CrossRef
Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial
Seung Tae Kim, Jason K. Sa, Sung Yong Oh, Kyung Kim, Jung Yong Hong, Won Ki Kang, Kyoung-Mee Kim, Jeeyun Lee
Genome Medicine.2021;[Epub]     CrossRef
Tumor immune response and immunotherapy in gastric cancer
Yoonjin Kwak, An Na Seo, Hee Eun Lee, Hye Seung Lee
Journal of Pathology and Translational Medicine.2020; 54(1): 20.     CrossRef
High-level FGFR2 amplification is associated with poor prognosis and Lower response to chemotherapy in gastric cancers
Joon Young Hur, Joseph Chao, Kyung Kim, Seung Tae Kim, Kyoung-Mee Kim, Samuel J. Klempner, Jeeyun Lee
Pathology - Research and Practice.2020; 216(4): 152878.     CrossRef
High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features
Xiaoqiao Liu, Min Gew Choi, Kyung Kim, Kyoung-Mee Kim, Seung Tae Kim, Se Hoon Park, Razvan Cristescu, Senaka Peter, Jeeyun Lee
Pathology - Research and Practice.2020; 216(4): 152881.     CrossRef
Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer
Jinchul Kim, Binnari Kim, So Young Kang, You Jeong Heo, Se Hoon Park, Seung Tae Kim, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim
Frontiers in Oncology.2020;[Epub]     CrossRef
First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients
Seung Tae Kim, Jung Yong Hong, Se Hoon Park, Joon Oh Park, Young Whan Park, Neunggyu Park, Hukeun Lee, Sung Hee Hong, Song-Jae Lee, Seong-Won Song, Kyung Kim, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Do-Hyun Nam, Jeong-Won Lee, Keunchil Park, Kyoung-Mee
Therapeutic Advances in Medical Oncology.2020; 12: 175883592092679.     CrossRef
Targeting the immune milieu in gastrointestinal cancers
Fiona Turkes, Justin Mencel, Naureen Starling
Journal of Gastroenterology.2020; 55(10): 909.     CrossRef
Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?
Federica Di Pinto, Raffaele Armentano, Graziana Arborea, Nicolò Schena, Rossella Donghia, Anna Maria Valentini
Oncology.2020; 98(8): 566.     CrossRef
MMR protein immunohistochemistry and microsatellite instability in gastric cancers
Junhun Cho, So Young Kang, Kyoung-Mee Kim
Pathology.2019; 51(1): 110.     CrossRef
Combination of Docetaxel Plus Savolitinib in Refractory Cancer Patients: A Report on Phase I Trial
Seung Tae Kim, Sujin Lee, Minhwa Park, Se Hoon Park, Joon Oh Park, Ho Yeong Lim, Young Suk Park, Won Ki Kang, Esha A. Gangolli, Hyeongchan Shin, Kyoung-Mee Kim, Simon J. Hollingsworth, Peter G.S. Mortimer, Jeeyun Lee
Translational Oncology.2019; 12(4): 597.     CrossRef
Bridging genomics and phenomics of gastric carcinoma
Junhun Cho, Soomin Ahn, Dae‐Soon Son, Nayoung KD Kim, Ki‐Wook Lee, Seungtae Kim, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Won Ki Kang, Ji Yeong An, Min Gew Choi, Jun‐Ho Lee, Tae Sung Sohn, Jae Moon Bae, Sung Kim, Kyoung‐Mee Kim
International Journal of Cancer.2019; 145(9): 2407.     CrossRef
Tumor microenvironment immune types in gastric cancer are associated with mismatch repair however, not HER2 status
Anna Valentini, Federica Di Pinto, Sergio Coletta, Vito Guerra, Raffaele Armentano, Maria Caruso
Oncology Letters.2019;[Epub]     CrossRef
Fatima M. Kipkeeva, Tatiana A. Muzaffarova, Maxim P. Nikulin, Pavel V. Apanovich, Alexander V. Karpukhin
Annals of the Russian academy of medical sciences.2018; 73(4): 262.     CrossRef
Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability
Junhun Cho, Young Hwan Chang, You Jeong Heo, Seungtae Kim, Nayoung K.D. Kim, Joon Oh Park, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim
ESMO Open.2018; 3(3): e000326.     CrossRef
Anti-programmed death ligand 1 (PD-L1) inhibitors in metastatic gastric cancer
Jang Ho Cho, Jeeyun Lee
Precision and Future Medicine.2017; 1(4): 152.     CrossRef
Identification of FGFR3-TACC3 gene fusion in metastatic gastric cancer
Youjin Kim, Seung Tae Kim, Jeeyun Lee, Won Ki Kang, Kyoung-Mee Kim, Se Hoon Park
Precision and Future Medicine.2017; 1(4): 168.     CrossRef